Holen Sie sich die Stockscreener-App
96.81
0.54%
-0.53
Handel nachbörslich:
97.03
0.22
+0.23%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LRCX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$97.34
Offen:
$96.59
24-Stunden-Volumen:
9.75M
Relative Volume:
0.85
Marktkapitalisierung:
$116.40B
Einnahmen:
$17.14B
Nettoeinkommen (Verlust:
$4.66B
KGV:
26.98
EPS:
3.588
Netto-Cashflow:
$3.79B
1W Leistung:
+1.23%
1M Leistung:
+19.83%
6M Leistung:
+34.03%
1J Leistung:
-8.72%
1-Tages-Spanne:
$94.49
$97.31
1-Wochen-Bereich:
$94.49
$98.02
52-Wochen-Spanne:
$56.32
$113.00
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Vergleichen Sie LRCX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
96.81 | 116.40B | 17.14B | 4.66B | 3.79B | 3.588 |
|
ASML
Asml Holding Nv
|
790.47 | 308.65B | 32.95B | 9.33B | 10.07B | 23.73 |
|
AMAT
Applied Materials Inc
|
183.76 | 139.45B | 28.09B | 6.76B | 5.86B | 8.22 |
|
KLAC
Kla Corp
|
898.85 | 113.28B | 11.55B | 3.70B | 3.51B | 27.51 |
|
TER
Teradyne Inc
|
91.92 | 14.23B | 2.91B | 577.07M | 608.44M | 3.54 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-24 | Bestätigt | TD Cowen | Buy |
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
Lam Research Corporation (NASDAQ:LRCX) Shares Sold by Fairvoy Private Wealth LLC - MarketBeat
Precedent Wealth Partners LLC Grows Stock Position in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Lam Research (NASDAQ:LRCX) Given New $115.00 Price Target at B. Riley - MarketBeat
B. Riley Securities Raises Price Target for Lam Research (LRCX) to $115 | LRCX Stock News - GuruFocus
Lam Research (LRCX): Analyst Boosts Price Target Citing Growth P - GuruFocus
Lam Research (LRCX): Analyst Boosts Price Target Citing Growth Potential | LRCX Stock News - GuruFocus
B. Riley Adjusts Price Target on Lam Research to $115 From $95, Maintains Buy Rating - MarketScreener
3,560 Shares in Lam Research Co. (NASDAQ:LRCX) Acquired by Rockland Trust Co. - MarketBeat
Asio Capital LLC Buys Shares of 29,970 Lam Research Co. (NASDAQ:LRCX) - MarketBeat
TD Cowen Lowers Lam Research (LRCX) Price Target, Keeps Buy Rating - Insider Monkey
10 Best American Semiconductor Stocks to Buy Now - Insider Monkey
Lam Research Sees Unusually High Options Volume (NASDAQ:LRCX) - MarketBeat
Breaking Down Lam Research: 19 Analysts Share Their Views - Benzinga
Lam Research (LRCX) Price Target Raised Amid Strong NAND and AI Demand | LRCX Stock News - GuruFocus
Oppenheimer Raises Price Target for Lam Research (LRCX) to $110 - GuruFocus
Here's How Much You Would Have Made Owning Lam Research Stock In The Last 10 Years - Benzinga
PKO Investment Management Joint Stock Co Has $6.25 Million Stake in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Oppenheimer Adjusts Price Target on Lam Research to $110 From $80, Maintains Outperform Rating - marketscreener.com
25,336 Shares in Lam Research Corporation (NASDAQ:LRCX) Purchased by Ritholtz Wealth Management - MarketBeat
Everhart Financial Group Inc. Takes Position in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Lam Research Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Lam Research Corp (LRCX)'s Winning Formula: Financial Metrics an - GuruFocus
Ex-Dividend Reminder: Lam Research, Southwest Airlines and Vishay Intertechnology - Nasdaq
Why Lam Research (LRCX) is a Top Stock for the Long-Term - Yahoo Finance
5 Technology Heavyweights That Surged in H1 & Have Room to Run in H2 - The Globe and Mail
Lam Research Corporation (NASDAQ:LRCX) Position Boosted by QRG Capital Management Inc. - MarketBeat
Marshall Financial Group LLC Makes New $2.35 Million Investment in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Pallas Capital Advisors LLC Takes $504,000 Position in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Trust Co. of Toledo NA OH Makes New Investment in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Mn Services Vermogensbeheer B.V. Decreases Holdings in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Grows Stock Holdings in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
BofA Boosts Lam Research (LRCX) Target to $100 Amid DRAM Tailwinds - Insider Monkey
Lam Research Co. (NASDAQ:LRCX) Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Lam Research Co. (NASDAQ:LRCX) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Handelsbanken Fonder AB Cuts Stock Position in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Azzad Asset Management Inc. ADV Takes $3.60 Million Position in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Elevation Point Wealth Partners LLC Sells 2,941 Shares of Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Lam Research Co. (NASDAQ:LRCX) Shares Acquired by Simon Quick Advisors LLC - MarketBeat
Sonora Investment Management Group LLC Decreases Position in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Lam Research (LRCX) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Avanza Fonder AB Has $8.02 Million Position in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Paragon Advisors LLC Has $2.08 Million Stake in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Cantor Fitzgerald Estimates Lam Research FY2026 Earnings - MarketBeat
Bar Harbor Wealth Management Invests $4.05 Million in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Lam Research Co. (NASDAQ:LRCX) Stock Position Raised by Integrated Advisors Network LLC - MarketBeat
UMB Bank n.a. Purchases New Position in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
Abacus FCF Advisors LLC Has $3.10 Million Stock Holdings in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
41,010 Shares in Lam Research Co. (NASDAQ:LRCX) Bought by Cetera Trust Company N.A - MarketBeat
10 Best Tech Stocks to Buy According to Billionaires - Insider Monkey
Lam Research Bets Big On ALD And Dry EUV: Will This Pay Off? - Barchart.com
Lam Research Bets Big on ALD and Dry EUV: Will This Pay Off? - The Globe and Mail
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lam Research Corp-Aktie (LRCX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Varadarajan Seshasayee | Senior Vice President |
Feb 20 '25 |
Sale |
90.00 |
110,080 |
9,907,200 |
179,084 |
0.35%
2.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):